Update in Asthma Management in Low-Middle Income Countries

Ian Lachner1, Manuel E Soto-Martínez1,2

  • 1Respiratory Department, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera", Caja Costarricense Seguro Social, San José, Costa Rica.

Pediatric Pulmonology
|November 27, 2024
PubMed

Insights

Asthma management is challenging in low and middle-income countries (LMICs) due to limited resources and healthcare access. Improving asthma control requires policy changes, better medication availability, and enhanced education for professionals and the public.

Area of Science:

  • Global Health
  • Respiratory Medicine
  • Public Health Policy

Background:

  • Asthma poses a significant global health burden, with disproportionately severe impacts in low and middle-income countries (LMICs).
  • Asthma management in LMICs is marked by poorer disease control and higher mortality rates compared to high-income nations.
  • Rising asthma prevalence and demographic shifts in LMICs indicate an increasing burden, particularly on children.

Purpose of the Study:

  • To highlight the challenges in asthma management within LMICs.
  • To identify key barriers to effective asthma care in resource-limited settings.
  • To propose actionable strategies for improving asthma control and adherence to international guidelines.

Main Methods:

  • Review of existing literature on asthma prevalence and management in LMICs.
  • Analysis of healthcare system limitations and medication access issues.
  • Examination of demographic trends and their impact on asthma burden.

Main Results:

  • Healthcare systems in LMICs often prioritize acute/infectious diseases over chronic conditions like asthma.
  • Limited access to and fluctuating availability of essential controller medications (inhaled corticosteroids) are critical barriers.
  • Many LMICs face infrastructural deficiencies and difficulties in healthcare access, hindering adherence to WHO guidelines.

Conclusions:

  • Effective asthma management in LMICs necessitates increased commitment from local healthcare providers and governmental policy changes.
  • Ensuring continuous access to controller medications is crucial for meeting minimum standards of care.
  • Implementing educational strategies for healthcare professionals and the public, alongside efforts to reduce smoking and air pollution, is vital for improving asthma outcomes.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
351
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.0K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
352
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
179